The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...
What's CODE SWITCH? It's the fearless conversations about race that you've been waiting for. Hosted by journalists of color, our podcast tackles the subject of race with empathy and humor. We explore ...
With a single click, unlock detailed, AI-assisted insights pulled from hundreds of financial data points instantly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback